Q2 2023 Holdings
Filed 2023-08-11 | 37 holdings | $289.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $22.0M | 241,690 | 7.6% |
| Prothena Corp PLC(PRTA) | SHS | G72800108 | $21.7M | 317,300 | 7.5% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $20.3M | 846,953 | 7.0% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $16.8M | 357,765 | 5.8% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $16.7M | 1,325,775 | 5.8% |
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $16.5M | 406,859 | 5.7% |
| Morphic Holding Inc | COM | 61775R105 | $16.5M | 287,556 | 5.7% |
| Springworks Therapeutics Inc | COM | 85205L107 | $16.0M | 608,628 | 5.5% |
| Cerevel Therapeutics Hldng I(CERE1EUR) | COM | 15678U128 | $15.7M | 492,545 | 5.4% |
| Moonlake Immunotherapeutics(MLTX) | CLASS A ORD | 61559X104 | $15.4M | 302,000 | 5.3% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $14.4M | 797,527 | 5.0% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $14.4M | 125,457 | 5.0% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $12.5M | 139,772 | 4.3% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $12.0M | 369,093 | 4.2% |
| Clarivate PLC(CLVT) | ORD SHS | G21810109 | $11.9M | 1,247,406 | 4.1% |
| Travere Therapeutics Inc(TVTX) | COM | 89422G107 | $11.7M | 761,721 | 4.0% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $10.2M | 411,500 | 3.5% |
| Bausch Health COS Inc(BHC) | COM | 071734107 | $9.3M | 1,165,000 | 3.2% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $8.8M | 701,570 | 3.0% |
| Solid Biosciences Inc(SLDB) | COM NEW | 83422E204 | $5.0M | 961,251 | 1.7% |
| Ares Acquisition Corp | *W EXP 02/02/202 | G33032122 | $403.8K | 504,706 | 0.1% |
| Bridgetown Holdings LTD | *W EXP 09/30/202 | G1355U121 | $222.0K | 895,000 | 0.1% |
| Churchill Capital Corp V | *W EXP 10/29/202 | 17144T115 | $110.2K | 612,000 | 0.0% |
| Churchill Capital Corp VI | *W EXP 02/17/202 | 17143W119 | $97.2K | 540,000 | 0.0% |
| First Light Acquisition Group Inc | *W EXP 03/14/202 | 320703119 | $85.2K | 655,200 | 0.0% |
| Churchill Capital Corp VII | *W EXP 02/29/202 | 17144M110 | $76.7K | 548,000 | 0.0% |
| Ross Acquisition Corp II | *W EXP 02/01/202 | G7641C114 | $74.4K | 439,666 | 0.0% |
| Compass Digital Acquisition Corp(COMP) | *W EXP 09/29/202 | G2476C123 | $68.4K | 459,906 | 0.0% |
| Swiftmerge Acquisition Corp | *W EXP 12/13/202 | G63836111 | $48.0K | 490,000 | 0.0% |
| Marblegate Acquisition Corp | *W EXP 08/31/202 | 56608A113 | $41.3K | 735,000 | 0.0% |
| Afternext Healthtech Acquisition Corp | *W EXP 99/99/999 | G01109126 | $31.8K | 366,666 | 0.0% |
| Conyers Park III Acquisition Corp | *W EXP 08/12/202 | 21289P110 | $28.6K | 571,666 | 0.0% |
| YS Biopharma Co LTD | *W EXP 03/15/202 | G9845F117 | $23.0K | 489,999 | 0.0% |
| Concord Acquisition Corp II | *W EXP 99/99/999 | 20607U116 | $16.3K | 408,333 | 0.0% |
| Home Plate Acquisition Corp | *W EXP 09/30/202 | 43734R111 | $14.7K | 690,000 | 0.0% |
| Bilander Acquisition Corp | *W EXP 05/19/202 | 09001T114 | $9.3K | 183,749 | 0.0% |
| Corsair Partnering Corp | *W EXP 07/06/202 | G2540H116 | $0 | 334,666 | 0.0% |